Joel S. Parker

123.6k citations

278 papers · 29.7k indexed · 12 hit papers · h-index 72

Molecular Biology top 0.1%
Cancer Research top 0.01%
Oncology top 0.05%
Pulmonary and Respiratory Medicine top 0.2%
Genetics top 0.2%

Co-authors: Charles M. Perou Xiaping He Aleix Prat Andrew B. Nobel J. S. Marron Philip S. Bernard Matthew J. Ellis Torsten O. Nielsen
Topics: Cancer Genomics and Diagnostics (52 papers)Breast Cancer Treatment Studies (39 papers)Gene expression and cancer classification (38 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Science Cell
Partner nations: United States Spain Canada

In The Last Decade

Joel S. Parker

266 papers receiving 29.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 4.0k citations Joel S. Parker, J. S. Marron et al. profile →
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

2009 3.1k citations Joel S. Parker, Maggie C.U. Cheang et al. profile →
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

2009 1.6k citations Maggie C.U. Cheang, Stephen Chia et al. profile →
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

2010 1.6k citations Aleix Prat, Joel S. Parker et al. profile →
Extensive post-transcriptional regulation of microRNAs and its implications for cancer

2006 691 citations Joel S. Parker et al. profile →
A custom microarray platform for analysis of microRNA gene expression

2004 644 citations Joel S. Parker, Charles M. Perou et al. profile →
Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

2014 613 citations Katherine A. Hoadley, Joel S. Parker et al. profile →
RNA polymerase is poised for activation across the genome

2007 596 citations Joel S. Parker et al. profile →
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer

2010 542 citations Torsten O. Nielsen, Joel S. Parker et al. Clinical Cancer Research profile →
Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression

2004 500 citations Christine H. Chung, Joel S. Parker et al. profile →
Increased Epidermal Growth Factor Receptor Gene Copy Number Is Associated With Poor Prognosis in Head and Neck Squamous Cell Carcinomas

2006 448 citations Christine H. Chung, Kim Ely et al. profile →
Male breast cancer: a disease distinct from female breast cancer

2018 230 citations Joel S. Parker, Sara R. Selitsky et al. profile →

Peers

Countries citing papers authored by Joel S. Parker

Since Specialization

Citations

This map shows the geographic impact of Joel S. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel S. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel S. Parker more than expected).

Fields of papers citing papers by Joel S. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel S. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel S. Parker. The network helps show where Joel S. Parker may publish in the future.

Co-authorship network of co-authors of Joel S. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Joel S. Parker. A scholar is included among the top collaborators of Joel S. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel S. Parker. Joel S. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Flexible analysis of spatial transcriptomics data (FAST): a deconvolution approach 2025 ·BMC Bioinformatics ·Meng Zhang,Joel S. Parker,Lingling An,Yiwen Liu,Xiaoxiao Sun	3
2	Type II innate lymphoid cell plasticity contributes to impaired reconstitution after allogeneic hematopoietic stem cell transplantation 2024 ·Nature Communications ·Sonia J. Laurie,(unknown),Danny Bruce,Hemamalini Bommiasamy,(unknown),Mostafa Yazdimamaghani,Samantha G. Pattenden,Nelson J. Chao,Stefanie Sarantopoulos,Joel S. Parker,Ian J. Davis,Jonathan S. Serody	4
3	Translating transcriptomic findings from cancer model systems to humans through joint dimension reduction 2023 ·Communications Biology ·(unknown),J. S. Marron,Lisle E. Mose,Charles M. Perou,Joel S. Parker	4
4	Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor–Positive Breast Cancer 2022 ·Clinical Cancer Research ·(unknown),Xiaping He,Lorna Renshaw,Carlos Martínez-Pérez,Charlene Kay,Mark Gray,James Meehan,Joel S. Parker,Charles M. Perou,Lisa A. Carey,J. Michael Dixon,Arran Turnbull	11
5	Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance) 2020 ·Clinical Cancer Research ·Federico Innocenti,Alexander B. Sibley,(unknown),Amy S. Etheridge,Chen Jiang,Fang‐Shu Ou,(unknown),Sarah J. Plummer,Graham Casey,Monica M. Bertagnolli,Howard L. McLeod,J. Todd Auman,Charles D. Blanke,Yoichi Furukawa,Alan P. Venook,Michiaki Kubo,Heinz‐Josef Lenz,Joel S. Parker,Mark J. Ratain,Kouros Owzar	13
6	Improved T-cell Receptor Diversity Estimates Associate with Survival and Response to Anti–PD-1 Therapy 2020 ·Cancer Immunology Research ·Dante S. Bortone,Mark G. Woodcock,Joel S. Parker,Benjamin G. Vincent	13
7	Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes 2019 ·Cancer Immunology Research ·Christof C. Smith,Shengjie Chai,(unknown),Samuel Lee,Elisa Landoni,(unknown),(unknown),Lisa M. Bixby,Sara R. Selitsky,Joel S. Parker,Barbara Savoldo,Jonathan S. Serody,Benjamin G. Vincent	47
8	Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma 2017 ·Cancer Research ·Aleix Prat,Alejandro Navarro,Laia Paré,Noemı́ Reguart,Patricia Galván,Tomás Pascual,Alex Martínez‐Martí,Paolo Nucíforo,Laura Comerma,Llúcia Alós,Núria Pardo,S. Cedrés,Cheng Fan,Joel S. Parker,Lydia Gaba,Iván Victoria,Núria Viñolas,Ana Vivancos,Ana Arance,Enriqueta Felip	277
9	Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression 2016 ·Clinical Cancer Research ·Samira A. Brooks,Amir H. Khandani,Julia R. Fielding,Weili Lin,(unknown),Yueh Z. Lee,Alexandra Arreola,Mathew I. Milowsky,Eric Wallen,Michael Woods,(unknown),(unknown),Joel S. Parker,David S. Lalush,W. Kimryn Rathmell	19
10	Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 2016 ·Molecular Cancer Research ·(unknown),(unknown),(unknown),(unknown),Frances Tong,Joel S. Parker,(unknown),Smita Ghanekar,W. Shannon Dillmore,(unknown)	9
11	Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA -Mutated and BRCA –Wild-Type Triple-Negative Breast Cancer 2015 ·Molecular Cancer Therapeutics ·Olga Karginova,Marni B. Siegel,Amanda E.D. Van Swearingen,Allison M. Deal,Bárbara Adamo,Maria J. Sambade,(unknown),Nana Nikolaishvili‐Feinberg,Ryan Bash,Sara O’Neal,(unknown),Joel S. Parker,Charlene Santos,David B. Darr,William C. Zamboni,Yueh Z. Lee,C. Ryan Miller,Carey K. Anders	53
12	BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization 2014 ·Cancer Research ·(unknown),Austin J. Hepperla,Vonn Walter,Shujie Song,Jeremy M. Simon,Joel S. Parker,Matthew D. Wilkerson,Nisarg Desai,Michael B. Major,D. Neil Hayes,Ian J. Davis,Bernard E. Weissman	102
13	Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer 2014 ·Clinical Cancer Research ·Michael D. Iglesia,Benjamin G. Vincent,Joel S. Parker,Katherine A. Hoadley,Lisa A. Carey,Charles M. Perou,Jonathan S. Serody	194
14	A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen 2012 ·Clinical Cancer Research ·Stephen Chia,Vivien Bramwell,Dongsheng Tu,Lois E. Shepherd,Shan Jiang,Tammi L. Vickery,Elaine R. Mardis,Samuel Leung,Karen Ung,Kathleen I. Pritchard,Joel S. Parker,Philip S. Bernard,Charles M. Perou,Matthew J. Ellis,Torsten O. Nielsen	220
15	Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial 2012 ·Clinical Cancer Research ·Maggie C.U. Cheang,K. David Voduc,Dongsheng Tu,Shan Jiang,Samuel Leung,Stephen Chia,Lois E. Shepherd,Mark N. Levine,Kathleen I. Pritchard,Sherri R. Davies,Inge J. Stijleman,Carole Davis,Mark Ebbert,Joel S. Parker,Matthew J. Ellis,Philip S. Bernard,Charles M. Perou,Torsten O. Nielsen	105
16	A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancerbreakdown → 2010 ·Clinical Cancer Research ·Torsten O. Nielsen,Joel S. Parker,Samuel Leung,D. Voduc,Mark Ebbert,Tammi L. Vickery,Sherri R. Davies,Jacqueline Snider,Inge J. Stijleman,Jerry P. Reed,Maggie C.U. Cheang,Elaine R. Mardis,Charles M. Perou,Philip S. Bernard,Matthew J. Ellis	542
17	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer 2009 ·Cancer Research ·Robert J. Crowder,Chanpheng Phommaly,Tao Yu,Jeremy Hoog,Jingqin Luo,Charles M. Perou,Joel S. Parker,Melinda A. Miller,David G. Huntsman,Lin Li,Jacqueline Snider,Sherri R. Davies,John A. Olson,Mark A. Watson,Anthony J. Saporita,Jason D. Weber,Matthew J. Ellis	174
18	A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle 2008 ·Cancer Research ·Ezra E.W. Cohen,Hongyan Zhu,Mark W. Lingen,Leslie E. Martin,Wen‐Liang Kuo,Eugene A. Choi,Masha Kocherginsky,Joel S. Parker,Christine H. Chung,Marsha Rich Rosner	67
19	Profiling Essential Genes in Human Mammary Cells by Multiplex RNAi Screening 2008 ·Science ·José M. Silva,Krista Marran,Joel S. Parker,Javier Silva,Michael C. Golding,Michael R. Schlabach,Stephen J. Elledge,Gregory J. Hannon,Kenneth Chang	225
20	Gene Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-κB Signaling as Characteristics of a High-risk Head and Neck Squamous Cell Carcinoma 2006 ·Cancer Research ·Christine H. Chung,Joel S. Parker,Kim Ely,(unknown),Yajun Yi,Barbara A. Murphy,K. Kian Ang,Adel K. El‐Naggar,Adam M. Zanation,Anthony J. Cmelak,Shawn Levy,Robbert J.C. Slebos,Wendell G. Yarbrough	197

About Joel S. Parker

Joel S. Parker is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 278 papers that have together received 29.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (52 papers), Breast Cancer Treatment Studies (39 papers) and Gene expression and cancer classification (38 papers). The work is most often cited by research in Cancer Research (13.2k citations), Oncology (11.4k citations) and Molecular Biology (16.2k citations). Joel S. Parker has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Charles M. Perou, Xiaping He, Aleix Prat, Andrew B. Nobel, J. S. Marron, Philip S. Bernard, Matthew J. Ellis, Torsten O. Nielsen, Maggie C.U. Cheang and Samuel Leung. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact